In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 118, Issue 9, Pages 1208-1216
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1038/s41416-018-0034-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer
- (2016) Keely May McNamara et al. BREAST CANCER RESEARCH AND TREATMENT
- Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas
- (2016) Mayu Takagi et al. BREAST CANCER RESEARCH AND TREATMENT
- Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions
- (2016) Erin E. Swinstead et al. CELL
- How far have we come in terms of estrogens in breast cancer? [Review]
- (2016) Keely May McNamara et al. ENDOCRINE JOURNAL
- Cooperative Dynamics of AR and ER Activity in Breast Cancer
- (2016) N. C. D'Amato et al. MOLECULAR CANCER RESEARCH
- Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer
- (2015) Rezvan Abduljabbar et al. BREAST CANCER RESEARCH AND TREATMENT
- Testosterone and breast cancer prevention
- (2015) R. Glaser et al. MATURITAS
- Beyond the C18 frontier: Androgen and glucocorticoid metabolism in breast cancer tissues
- (2015) Keely May McNamara et al. STEROIDS
- Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes
- (2014) Keely M. McNamara et al. BREAST CANCER RESEARCH AND TREATMENT
- Complexities of androgen receptor signalling in breast cancer
- (2014) Keely M McNamara et al. ENDOCRINE-RELATED CANCER
- A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer
- (2013) R. Charles Coombes et al. BREAST CANCER RESEARCH AND TREATMENT
- HER2 and Breast Cancer Stem Cells: More than Meets the Eye
- (2013) H. Korkaya et al. CANCER RESEARCH
- Androgenic pathway in triple negative invasive ductal tumors: Its correlation with tumor cell proliferation
- (2013) Keely M. McNamara et al. CANCER SCIENCE
- Androgen receptor in triple negative breast cancer
- (2012) K.M. McNamara et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Activation of the Glucocorticoid Receptor Is Associated with Poor Prognosis in Estrogen Receptor-Negative Breast Cancer
- (2011) D. Pan et al. CANCER RESEARCH
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
- (2011) Biswajyoti Sahu et al. EMBO JOURNAL
- Steroid sulfatase inhibitors: Promising new tools for breast cancer therapy?
- (2011) Jürgen Geisler et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Steroid sulfatase inhibitors: A review covering the promising 2000–2010 decade
- (2011) René Maltais et al. STEROIDS
- Aromatase immunoreactivity is increased in mammographically dense regions of the breast
- (2010) Celine M. Vachon et al. BREAST CANCER RESEARCH AND TREATMENT
- Effects of estrogen on the proportion of stem cells in the breast
- (2010) Bruno M. Simões et al. BREAST CANCER RESEARCH AND TREATMENT
- Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status
- (2009) P.E. Lønning et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2009) Jonathan D Marotti et al. MODERN PATHOLOGY
- In situestrogen production and its regulation in human breast carcinoma: From endocrinology to intracrinology
- (2009) Hironobu Sasano et al. PATHOLOGY INTERNATIONAL
- Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs
- (2008) Michael C. Byrns et al. CHEMICO-BIOLOGICAL INTERACTIONS
- A New Therapeutic Strategy against Hormone-Dependent Breast Cancer: The Preclinical Development of a Dual Aromatase and Sulfatase Inhibitor
- (2008) P. A. Foster et al. CLINICAL CANCER RESEARCH
- Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents†
- (2008) Mathew P. Leese et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients
- (2008) Masayo Suzuki et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started